US stocks were poised to resume their record-setting climb on Tuesday, as investors assessed concerns about a pullback in the wait for Federal Reserve chair Jerome Powell to speak.
S&P 500 futures (ES=F) edged up 0.2%, while those on the tech-heavy Nasdaq 100 (NQ=F) led the way higher with a 0.4% gain. Dow Jones Industrial Average (YM=F) futures were little changed.
Stocks have ground out fresh all-time highs as signs of a US economic slowdown bolster bets on interest-rate cuts. The benchmark S&P 500 (^GSPC) booked its 35th record close of the year on Monday, while the Nasdaq Composite (^IXIC) took out a record of its own as chip stocks outperformed.
Powell should shed light on the Fed’s picture of the economy when he gives his twice-yearly policy update to Congress, starting Tuesday with an appearance in the Senate. Testimony to the House follows the next day, setting the stage for a key update on consumer inflation on Thursday — all potential catalysts for stocks if they confirm a cooling.
But a note of caution is seeping into the market as the idea of a summer pullback gets more backers, with Morgan Stanley strategist Mike Wilson calling for a 10% correction.
Wall Street is getting cold feet about this coming earnings season, given the higher bar of expectations they face this time around. At the same time, investors are starting to question the huge inflows into AI-linked stocks that have driven the recent rally, given the tech’s impact is still unproven.
On the corporate front, BP’s (BP) US-listed shares fell over 4% in pre-market trading after the energy giant warned of a refining slump and factory-linked writedown of up to $2 billion. Meanwhile, Novo Nordisk (NVO) stock slipped after Wegovy lost out to Eli Lilly’s (LLY) Mounjaro in an analysis of rival weight-loss drugs.
Live2 updates